- Home
- ENTX vs QUIK Comparison
ENTX vs QUIK Comparison
Compare ENTX & QUIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENTX
- QUIK
- Stock Information
- Founded
- ENTX 2010
- QUIK 1988
- Country
- ENTX Israel
- QUIK United States
- Employees
- ENTX N/A
- QUIK N/A
- Industry
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- QUIK Semiconductors
- Sector
- ENTX Health Care
- QUIK Technology
- Exchange
- ENTX Nasdaq
- QUIK Nasdaq
- Market Cap
- ENTX 104.0M
- QUIK 87.3M
- IPO Year
- ENTX 2018
- QUIK 1997
- Fundamental
- Price
- ENTX $1.98
- QUIK $5.89
- Analyst Decision
- ENTX Strong Buy
- QUIK Strong Buy
- Analyst Count
- ENTX 1
- QUIK 3
- Target Price
- ENTX $10.00
- QUIK $10.87
- AVG Volume (30 Days)
- ENTX 43.1K
- QUIK 134.9K
- Earning Date
- ENTX 08-08-2025
- QUIK 08-12-2025
- Dividend Yield
- ENTX N/A
- QUIK N/A
- EPS Growth
- ENTX N/A
- QUIK N/A
- EPS
- ENTX N/A
- QUIK N/A
- Revenue
- ENTX $223,000.00
- QUIK $18,768,000.00
- Revenue This Year
- ENTX N/A
- QUIK $11.58
- Revenue Next Year
- ENTX N/A
- QUIK $40.23
- P/E Ratio
- ENTX N/A
- QUIK N/A
- Revenue Growth
- ENTX N/A
- QUIK N/A
- 52 Week Low
- ENTX $1.41
- QUIK $4.26
- 52 Week High
- ENTX $2.79
- QUIK $13.36
- Technical
- Relative Strength Index (RSI)
- ENTX 48.00
- QUIK 54.14
- Support Level
- ENTX $1.87
- QUIK $5.66
- Resistance Level
- ENTX $2.18
- QUIK $6.06
- Average True Range (ATR)
- ENTX 0.18
- QUIK 0.31
- MACD
- ENTX -0.00
- QUIK 0.02
- Stochastic Oscillator
- ENTX 31.82
- QUIK 50.29
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.
About QUIK QuickLogic Corporation
QuickLogic Corp provides programmable silicon and software platforms to enable its customers to develop custom hardware products in a fast time-to-market and cost-effective way. QuickLogic is a fabless semiconductor company with a product range: embedded FPGA (eFPGA) intellectual property (IP), low power, multi-core semiconductor system-on-chips (SoCs), discrete FPGAs, and AI software. The full range of platforms, software tools, and eFPGA IP enables the practical and efficient adoption of AI, voice, and sensor processing across Aerospace, and Defense, Consumer/Industrial IoT, and Consumer Electronics markets.